Atlas Trials

UC (Urothelial Cancer)

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch UC (Urothelial Cancer)

RecordFirmDate
Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma (NCT03374488)Incyte Corporation2017-12-22
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201) (NCT02872714)Incyte Corporation2017-01-12
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors (NCT02903914)Incyte Corporation2016-09-14
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors (NCT02646748)Incyte Corporation2016-01-25
A Study of Atezolizumab in Combination With Epacadostat in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma (NCT02298153)Incyte Corporation2015-01-27
A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203) (NCT02318277)Incyte Corporation2015-01-05
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers (NCT02178722)Incyte Corporation2014-07-17

Track UC (Urothelial Cancer) automatically

Every clearance here is in the API, with alerts when new ones post.